Uncategorized

New Longevity event to debut in Croatia

Aging2.0 announces inaugural VOLTAGE event, connecting entrepreneurs and innovators to build a single market for active and healthy aging in Europe. This April, Aging2.0 will...

AI biomarker built to measure brain age

University of Oslo researchers develop AI biomarker for tracking neurological treatment over time. Finding timely therapies for age begins with finding a way to measure...

Why Longevity, why now?

Our Editor-in-Chief, Phil Newman, addresses why Longevity will become the biggest opportunity of our time. Healthcare has already migrated from ‘cure’ to ‘intervention’ and will...

Latest articles

Building an artificial immune system

DoD-funded ThirdLaw Technologies to harness the power of ‘spiroligomers’ to rapidly build new small molecules for Longevity therapies. Far from the world of stock market...

Neurotech is the new blue ocean

Alon Braun, Co-Founder, Neurotech Analytics.

Amazon and K4Connect demonstrate scalability for agetech

Covid-19 has been difficult for everyone, but particularly for people over the age of 65 who may spend months shut away from loved ones...

“Avoid the use of DQ as a senolytic therapy”

Forever Healthy Foundation issues risk-benefit analysis on dasatinib + quercetin as a senolytic. The Forever Healthy Foundation today published its latest risk-benefit analysis, which explores...